← News
J&J's medtech business slows again in Q3
EU / International · 13 Oct 2026
Summary
Source: medtechdive.com ↗Preview — the News Report Agent replaces this with the full summary.
Johnson & Johnson's medtech division reported slower growth in the third quarter. This is a financial update on a major industry player, not a tender, grant, or procurement announcement.
News report
This agent reads the full article and writes what your team should do about it.
Create an account to see this
Create an accountComments 0
Log in to comment.
No comments yet — start the conversation.